Circulating osteoprotegerin (OPG) is a biomarker for cardiovascular complications that are closely related to chronic kidney disease (CKD). To investigate the association between circulating OPG level with long-term visit-to-visit blood pressure variability (BPV) in patients with pre-dialysis CKD, a total of 1855 subjects with CKD from stage 1 to pre-dialysis stage 5 from a prospective cohort were analyzed. Long-term visit-to-visit BPV was determined by average real variability (ARV), standard deviation (SD), and coefficient of variation (CoV) of systolic and diastolic blood pressure (SBP and DBP). ARV of SBP (Adjusted β coefficient 0.143, 95% confidence interval 0.021 to 0.264) was significantly associated with serum OPG level. Although SD...
BackgroundCardiovascular disease is the leading cause of death in chronic kidney disease and hemodia...
BACKGROUND AND AIMS: Vascular calcification (VC) and atherosclerosis are associated with an increa...
Rationale & objective: Optimal blood pressure (BP) control is a major therapeutic strategy in the ma...
Osteoprotegerin (OPG) is a glycoprotein that plays an important regulatory role in the skeletal, vas...
INTRODUCTION: Hypertension has been one of the major factors responsible for decline in renal func...
Background: Osteoprotegerin (OPG) belongs to the tumour necrosis factor superfamily and is known to ...
Background Osteoprotegerin is an important regulator of bone metabolism and vascular calcification. ...
Background Whether visit‐to‐visit systolic blood pressure (SBP) variability can predict major advers...
Cardiovascular disease is the leading cause of death in chronic kidney disease and hemodialysis popu...
Cardiovascular disease is the major cause of morbidity and mortality in chronic kidney disease (CKD)...
BackgroundTo evaluate osteoprotegerin (OPG) levels in relation to cardiovascular (CV) risk factors i...
BACKGROUND/AIMS: Osteoprotegerin (OPG) and fetuin-A are vascular calcification regulators that may b...
Cardiovascular calcifications (CVC) are frequently observed in chronic kidney disease (CKD) patients...
Joanna Kamińska,1,* Marek Stopiński,1,* Krzysztof Mucha,2,3 Michał Pac,2 Marek Gołębiowski,4 Monika ...
OBJECTIVE:Previous studies have shown that visit-to-visit blood pressure variability (BPV) is associ...
BackgroundCardiovascular disease is the leading cause of death in chronic kidney disease and hemodia...
BACKGROUND AND AIMS: Vascular calcification (VC) and atherosclerosis are associated with an increa...
Rationale & objective: Optimal blood pressure (BP) control is a major therapeutic strategy in the ma...
Osteoprotegerin (OPG) is a glycoprotein that plays an important regulatory role in the skeletal, vas...
INTRODUCTION: Hypertension has been one of the major factors responsible for decline in renal func...
Background: Osteoprotegerin (OPG) belongs to the tumour necrosis factor superfamily and is known to ...
Background Osteoprotegerin is an important regulator of bone metabolism and vascular calcification. ...
Background Whether visit‐to‐visit systolic blood pressure (SBP) variability can predict major advers...
Cardiovascular disease is the leading cause of death in chronic kidney disease and hemodialysis popu...
Cardiovascular disease is the major cause of morbidity and mortality in chronic kidney disease (CKD)...
BackgroundTo evaluate osteoprotegerin (OPG) levels in relation to cardiovascular (CV) risk factors i...
BACKGROUND/AIMS: Osteoprotegerin (OPG) and fetuin-A are vascular calcification regulators that may b...
Cardiovascular calcifications (CVC) are frequently observed in chronic kidney disease (CKD) patients...
Joanna Kamińska,1,* Marek Stopiński,1,* Krzysztof Mucha,2,3 Michał Pac,2 Marek Gołębiowski,4 Monika ...
OBJECTIVE:Previous studies have shown that visit-to-visit blood pressure variability (BPV) is associ...
BackgroundCardiovascular disease is the leading cause of death in chronic kidney disease and hemodia...
BACKGROUND AND AIMS: Vascular calcification (VC) and atherosclerosis are associated with an increa...
Rationale & objective: Optimal blood pressure (BP) control is a major therapeutic strategy in the ma...